openPR Logo
Press release

52Platform Introduces Bleuler: A Revolutionary Advance in Schizophrenia Treatment Personalization

01-24-2025 09:14 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: Notorial
52Platform Introduces Bleuler: A Revolutionary Advance

Image: https://www.globalnewslines.com/uploads/2025/01/1737641669.jpg

Barcelona - January 24, 2025 - 52Platform [https://www.52platform.com/], a leader in neuroscientific innovation, has announced Bleuler, a groundbreaking project to develop a platform designed to transform the treatment of schizophrenia. Engineered with the most advanced capabilities of artificial intelligence, Bleuler aims to provide personalized solutions based on precise data. This international project involves collaboration with Synaptia Health Group [https://synaptia.es/] in Spain, MJN Neuro, the National Institute of Neurology and Neurosurgery "Manuel Velasco Suarez" in Mexico, and Rey Juan Carlos University.

Schizophrenia affects over 25 million people worldwide. This disorder presents significant challenges due to variability in patient responses to current treatments. Bleuler, still in the study phase, focuses on developing an innovative clinical approach that combines electroencephalographic biomarkers and advanced cognitive assessments through artificial intelligence.

"Bleuler has the potential to revolutionize the medical care of schizophrenia", stated Adrian Trejo de la Rosa [https://www.linkedin.com/in/adrian-trejo-de-la-rosa/?originalSubdomain=es], CEO and co-founder of 52Platform. "This project is a step towards more precise treatment that will improve the quality of life for patients and provide doctors with reliable technological tools for making critical decisions. Our vision does not stop here; we want to expand this model to other neurological disorders and continue leading the future of personalized medicine".

The development of Bleuler will be possible thanks to a grant of 973,811.33 Euros from a total budget of 1,604,067 Euros, awarded by the Center for Technological Development and Innovation (CDTI), a Public Business Entity under the Ministry of Science, Innovation, and Universities. This funding, as part of its program to support high-impact R&D projects, will allow progress in research, validate the technology, and refine the platform's design.

Technological Innovation at the Service of Patients

Bleuler seeks to detect early clinical changes in patients and adjust treatments according to their individual needs. Current studies include the development of wearable devices capable of monitoring brain activity from home, combined with automated cognitive analysis systems. These tools are designed to improve the quality of care and reduce unnecessary hospitalizations.

The project is expected to be ready for implementation in November 2026. This goal reinforces the collaborators' commitment to offering a solution that optimizes the treatment of schizophrenia in both public and private institutions. Besides the clinical impact, Bleuler aims to improve the sustainability of the healthcare system in the long term by reducing costs associated with prolonged treatments. Although the platform is still under development, the projected advancements promise significant benefits for patients and health systems alike.

"Bleuler marks the beginning of a new era in personalized medicine", concluded Trejo de la Rosa. "We are committed to developing innovative solutions that not only transform the treatment of schizophrenia but also set new standards for other complex disorders".
Media Contact
Company Name: 52Platform
Contact Person: Press Office
Email: Send Email [http://www.universalpressrelease.com/?pr=52platform-introduces-bleuler-a-revolutionary-advance-in-schizophrenia-treatment-personalization]
Country: United States
Website: https://www.52platform.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 52Platform Introduces Bleuler: A Revolutionary Advance in Schizophrenia Treatment Personalization here

News-ID: 3832682 • Views:

More Releases from Getnews

Momentum Advisors Expands Financial Planning Services for Athletes with Leadership from Will Platt, CFP Registered
Momentum Advisors Expands Financial Planning Services for Athletes with Leadersh …
Image: https://www.globalnewslines.com/uploads/2025/09/1757341514.jpg Momentum Advisors NEW YORK, NY - Momentum Advisors LLC [https://momentumadvisorspodcast.com/], one of the nation's largest minority-owned registered investment advisory firms, announces the continued growth of its specialized financial planning services for athletes, led by Will Platt, CFP [https://www.momentum-advisors.com/william-platt] Registered , Head of Financial Planning and Managing Partner. A former collegiate football player turned financial advisor, Platt has built a planning practice uniquely devoted to helping athletes navigate the complexities
Rupert Rodney announces the appointment of Christina Stewart as Marketing Associate.
Rupert Rodney announces the appointment of Christina Stewart as Marketing Associ …
Image: https://www.globalnewslines.com/uploads/2025/09/1757111791.jpg Rupert Rodney, the strategic growth firm helping visionary CEOs and executive teams close the Clarity Gap Trademark , proudly announces the appointment of Christina Stewart as Marketing Associate. Toronto, ON - September 08, 2025 - Rupert Rodney, the strategic growth firm helping visionary CEOs and executive teams close the Clarity Gap Trademark , proudly announces the appointment of Christina Stewart as Marketing Associate. This promotion follows her high-impact contributions
New Era of Coaching: Entrepreneurs Seek Trust, Integrity, and Measurable Results
New Era of Coaching: Entrepreneurs Seek Trust, Integrity, and Measurable Results
Image: https://www.globalnewslines.com/uploads/2025/09/1757342990.jpg As skepticism grows in the coaching industry, entrepreneurs are embracing Strategic Risk Reversal Trademark , an integrity-first model that lowers client risk and accelerates results. Early adopters have already reached million-dollar milestones, signaling a shift toward trust-driven, measurable coaching outcomes. Wilmington, Delaware - September 08, 2025 - With lawmakers, consumer watchdogs, and media increasingly scrutinizing predatory practices in online education and coaching, ICONMAKER Registered is breaking new ground. The company
Revenue Sage Launches RainmakerOS to Help Lean Teams Modernize Sales with AI-Powered Growth Infrastructure
Revenue Sage Launches RainmakerOS to Help Lean Teams Modernize Sales with AI-Pow …
RainmakerOS integrates data, automation, and AI agents into a unified platform for founders, consultants, and growth teams seeking scalable, efficient go-to-market systems. LEWES, DE - September 8, 2025 - Revenue Sage Trademark , a strategy-first AI consultancy and fractional executive collective, has announced the launch of RainmakerOS Trademark , an AI-powered revenue operating system built to help modern go-to-market teams streamline growth with fewer resources. Designed for founder-led businesses, fractional executives, and

All 5 Releases


More Releases for Bleuler

Revolutionary Breakthrough for Schizophrenia; Bleuler by 52Platform Receives Fun …
Image: https://www.globalnewslines.com/uploads/2025/01/1737537886.jpg Bleuler seeks to redefine clinical management with advanced artificial intelligence and personalized solutions. The project aims to improve patients' quality of life and optimize healthcare system costs. 52Platform [https://www.52platform.com/], a leader in neuroscientific innovation, has announced Bleuler, a revolutionary project aimed at developing a platform to transform the treatment of schizophrenia. Designed with the most advanced capabilities of artificial intelligence, Bleuler aspires to provide personalized solutions based on accurate data. This